BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11289658)

  • 1. Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia.
    Gühring H; Tegeder I; Lötsch J; Pahl A; Werner U; Reeh PW; Rehse K; Brune K; Geisslinger G
    Inflamm Res; 2001 Feb; 50(2):83-8. PubMed ID: 11289658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice.
    Gühring H; Görig M; Ates M; Coste O; Zeilhofer HU; Pahl A; Rehse K; Brune K
    J Neurosci; 2000 Sep; 20(17):6714-20. PubMed ID: 10964977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord.
    Sung CS; Wen ZH; Chang WK; Chan KH; Ho ST; Tsai SK; Chang YC; Wong CS
    J Neurochem; 2005 Aug; 94(3):742-52. PubMed ID: 16033422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase.
    Tao F; Tao YX; Mao P; Zhao C; Li D; Liaw WJ; Raja SN; Johns RA
    Neuroscience; 2003; 120(3):847-54. PubMed ID: 12895524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation.
    Salvemini D; Wang ZQ; Wyatt PS; Bourdon DM; Marino MH; Manning PT; Currie MG
    Br J Pharmacol; 1996 Jun; 118(4):829-38. PubMed ID: 8799551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord.
    Sung CS; Wen ZH; Chang WK; Ho ST; Tsai SK; Chang YC; Wong CS
    Brain Res; 2004 Jul; 1015(1-2):145-53. PubMed ID: 15223378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased central and peripheral inflammation and inflammatory hyperalgesia in Zucker rat model of leptin receptor deficiency and genetic obesity.
    Iannitti T; Graham A; Dolan S
    Exp Physiol; 2012 Nov; 97(11):1236-45. PubMed ID: 22523380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation.
    Tang Q; Svensson CI; Fitzsimmons B; Webb M; Yaksh TL; Hua XY
    Eur J Neurosci; 2007 May; 25(10):2964-72. PubMed ID: 17561811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm.
    Harkin DW; Rubin BB; Romaschin A; Lindsay TF
    J Surg Res; 2004 Aug; 120(2):230-41. PubMed ID: 15234218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide in the rat spinal cord in Freund's adjuvant-induced hyperalgesia.
    Yonehara N; Takemura M; Yoshimura M; Iwase K; Seo HG; Taniguchi N; Shigenaga Y
    Jpn J Pharmacol; 1997 Dec; 75(4):327-35. PubMed ID: 9469638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic administration of nitric oxide synthase inhibitors reverses hyperalgesia but not inflammation in a rat model of polyarthritis.
    Tedesco LS; Fuseler J; Grisham M; Wolf R; Roerig SC
    Pain; 2002 Feb; 95(3):215-223. PubMed ID: 11839421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for spinal nitric oxide in mediating visceral hyperalgesia in the rat.
    Coutinho SV; Gebhart GF
    Gastroenterology; 1999 Jun; 116(6):1399-408. PubMed ID: 10348823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice.
    Phillipson M; Henriksnäs J; Holstad M; Sandler S; Holm L
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G154-62. PubMed ID: 12646421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain.
    De Alba J; Clayton NM; Collins SD; Colthup P; Chessell I; Knowles RG
    Pain; 2006 Jan; 120(1-2):170-181. PubMed ID: 16360270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice.
    Boettger MK; Uceyler N; Zelenka M; Schmitt A; Reif A; Chen Y; Sommer C
    Eur J Pain; 2007 Oct; 11(7):810-8. PubMed ID: 17395508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents that act by different mechanisms modulate the activity of protein kinase CbetaII isozyme in the rat spinal cord during peripheral inflammation.
    Igwe OJ
    Neuroscience; 2006; 138(1):313-28. PubMed ID: 16360284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni.
    Jean YH; Chen WF; Duh CY; Huang SY; Hsu CH; Lin CS; Sung CS; Chen IM; Wen ZH
    Eur J Pharmacol; 2008 Jan; 578(2-3):323-31. PubMed ID: 17916350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice.
    Pol O; Sasaki M; Jiménez N; Dawson VL; Dawson TM; Puig MM
    Br J Pharmacol; 2005 Jul; 145(6):758-66. PubMed ID: 15852037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of intrathecally and intracerebroventricularly administered nitric oxide donors on noxious mechanical and thermal stimulation.
    Machelska H; Przewłocki R; Radomski MW; Przewłocka B
    Pol J Pharmacol; 1998; 50(6):407-15. PubMed ID: 10385923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.